Basic Science and Pathogenesis

Area of Science:

• Neuroscience
• Mitochondrial Biology
• Alzheimer's Disease Research

Background:

• Mitochondrial dysfunction and excessive mitochondrial calcium (_mCa²⁺) accumulation in neurons are early hallmarks of Alzheimer's disease (AD).
• AD pathology involves complex interactions between neurons, microglia, and astrocytes, but cell-specific mechanisms of mitochondrial calcium handling remain poorly understood.
• This study investigates cell-type-specific differences in _mCa²⁺ flux and signaling in the context of AD.

Purpose of the Study:

• To investigate cell-type-specific differences in mitochondrial calcium (_mCa²⁺) flux and signaling in neuronal, microglial, and astrocyte cell lines under normal and AD conditions.
• To understand the role of cell-specific mitochondrial calcium dynamics in Alzheimer's disease pathology.
• To identify potential therapeutic targets by elucidating the regulatory mechanisms of _mCa²⁺ signaling dysregulation.

Main Methods:

• Generated human neuronal (SH-SY5Y), microglia (HMC3), and astrocyte (SVGp12) cell lines with AD-linked APP mutations (APPswe/F/L).
• Assessed mitochondrial calcium uniporter (mtCU) expression, _mCa²⁺ influx/efflux using Fura-FF, and mitochondrial calcium retention capacity (CRC).
• Measured ATP, NADH, cell death, mitochondrial structure, membrane potential, mitochondrial ROS, and lactylation to evaluate cellular bioenergetics and mitochondrial function.

Main Results:

• Mitochondrial dysfunction was observed in all brain cell types, with neurons exhibiting the highest susceptibility to cell death and reduced bioenergetics.
• Astrocytes and microglia demonstrated elevated _mCa²⁺ signaling, higher calcium uptake rates, and greater calcium retention capacity compared to neurons.
• Cell-specific differences in lactylation were identified, with significantly higher expression in microglia and astrocytes, suggesting a role in mitochondrial functional regulation.

Conclusions:

• Cell-specific mitochondrial calcium (_mCa²⁺) signaling dynamics significantly influence the metabolic and pathophysiological contributions of different brain cells to Alzheimer's disease.
• Understanding the regulatory mechanisms of _mCa²⁺ signaling dysregulation in each cell type is crucial for developing targeted therapeutic strategies.
• The findings offer insights into mitochondrial bioenergetics, cell death pathways, and AD progression, supporting novel therapeutic approaches for AD.